Influence of silybin on biophysical properties of phospholipid bilayers

Acta Pharmacologica Sinica

Volumn 28, Issue 2, 2007, Pages 296-306

  Wesołowska, Olga ^a   Łania Pietrzak, Barbara ^a   Kuzdzał, Micha ^a   Stańaczak, Kamila ^a   Mosia̧dz, Daniela ^a   Dobryszycki, Piotr ^b   Ozyhar, Andrzej ^b   Komorowska, Małgorzata ^b,c   Hendrich, Andrzej B ^a   Michalak, Krystyna ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b WROCLAW UNIVERSITY OF TECHNOLOGY   (Poland)

^c NONE   (Poland)

Author keywords

Electron spin resonance; Flavonoids; Fluorescence spectroscopy; Microcalorimetry; Phospholipid bilayer; Silybin (silibinin)

Indexed keywords

FLUORESCENT DYE; PHOSPHATIDYLCHOLINE; SILIBININ;

ARTICLE; BIOLOGICAL ACTIVITY; ELECTRON SPIN RESONANCE; FLUORESCENCE SPECTROSCOPY; MICROCALORIMETRY; PHOSPHOLIPID BILAYER; TRANSITION TEMPERATURE;

1,2-DIPALMITOYLPHOSPHATIDYLCHOLINE; CALORIMETRY, DIFFERENTIAL SCANNING; DIMYRISTOYLPHOSPHATIDYLCHOLINE; ELECTRON SPIN RESONANCE SPECTROSCOPY; FLUORESCENCE; LIPID BILAYERS; MODELS, MOLECULAR; PHOSPHOLIPIDS; SILYMARIN;

EID: 33846516269     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2007.00487.x     Document Type: Article

References (38)

1. Crocenzi FA, Roma MG. Silymarin as a new hepatoprotective agent in experimental cholestasis: new possibilities for an ancient medication. Curr Med Chem 2006; 13: 1055-74.
2. Giese LA. Milk thistle and the treatment of hepatitis. Gastroenterol Nurs 2001; 24: 95-7.
3. Hendrich AB. Flavonoid-membrane interactions: possible consequences for biological effects of some polyphenolic compounds. Acta Pharmacol Sin 2006: 27: 27-40.
4. Sharma G, Singh RP, Chan DC, Agarwal R. Silibinin induces growth inhibition and apoptotic cell death in human lung carcinoma cells. Anticancer Res 2003; 23: 2649-55.
5. Singh RP, Agarwal R. Prostate cancer prevention by silibinin. Curr Cancer Drug Targets 2004; 4: 1-11.
6. Gallo D, Giacomelli S, Ferlini C, Raspaglio G, Apollonio P, Prislei S, et al. Antitumour activity of the silybin-phosphatidylcholine complex, IdB 1016, against human ovarian cancer. Eur J Cancer 2003: 39: 2403-10.
7. de Monbrison F, Maitrejean M, Latour C, Bugnazet F, Peyron F, Barron D, et al. In vitro antimalarial activity of flavonoid derivatives dehydrosilybin and 8-(1;1)-DMA-kaempferide. Acta Trop 2006; 97: 102-7.
8. Valenzuela A, Garrido A. Biochemical bases of the pharmacological action of the flavonoid silymarin and of its structural isomer silibinin. Biol Res 1994; 27: 105-12.
9. Maitrejean M, Comte G, Barron D, El Kirat K, Conseil G, Di Pietro A. The flavanolignan silybin and its hemisynthetic derivatives, a novel series of potential modulators of P-glycoprotein. Bioorg Med Chem Lett 2000; 10: 157-60.
10. Nguyen H, Zhang S, Morris ME. Effect of flavonoids on MRP1-mediated transport in Panc-1 cells. J Pharm Sci 2003; 92: 250-7.
11. Wu CP, Calcagno AM, Hladky SB, Ambudkar SV, Barrand MA. Modulatory effects of plant phenols on human multidrug-resistance proteins 1, 4 and 5 (ABCC1, 4 and 5). FEBS J 2005; 272: 4725-40.
12. Cooray HC, Janvilisri, van Veen HW, Hladky SB, Barrand MA. Interaction of the breast cancer resistance protein with plant polyphenols. Biochem Biophys Res Commun 2004; 317: 269-75.
13. Zhang S, Yang X, Morris ME. Combined effects of multiple flavonoids on breast cancer resistance protein (ABCG2)-mediated transport. Pharm Res 2004; 21: 1263-73.
14. Lania-Pietrzak B, Michalak K, Hendrich AB, Mosiadz D, Grynkiewicz G, Motohashi N, et al. Modulation of MRP1 protein transport by plant, and synthetically modified flavonoids. Life Sci 2005; 77: 1879-91.
15. Trompier D, Baubichon-Cortay H, Chang XB, Maitrejean M, Barron D, Riordon JR, et al. Multiple flavonoid-binding sites within multidrug resistance protein MRP1. Cell Mol Life Sci 2003; 60: 2164-77.
16. Barzaghi N, Crema F, Gatti G, Pifferi G, Perucca E. Pharmacokinetic studies on IdB 1016, a silybin-phosphatidylcholine complex, in healthy human subjects. Eur J Drug Metab Pharmacokinet 1990; 15: 333-8.
17. Carini R, Comoglio A, Albano E, Poli G. Lipid peroxidation and irreversible damage in the rat hepatocyte model. Protection by the silybin-phospholipid complex IdB 1016. Biochem Pharmacol 1992; 43: 2111-5.
18. Comoglio A, Tomasi A, Malandrino S, Poli G, Albano E. Scavenging effect of silipide, a new silybin-phospholipid complex, on ethanol-derived free radicals. Biochem Pharmacol 1995; 50: 1313-6.
19. Maheshwari H, Agarwal R, Patil C, Katare OP. Preparation and pharmacological evaluation of silibinin liposomes. Arzneimittelforschung 2003; 53: 420-7.
20. Letteron P, Labbe G, Degott C, Berson A, Fromenty B, Delaforge M, et al. Mechanism for the protective effects of silymarin against carbon tetrachloride-induced lipid peroxidation and hepatotoxicity in mice. Evidence that silymarin acts both as an inhibitor of metabolic activa tion and as a chain-breaking antioxidant. Biochem Pharmacol 1990; 39: 2027-34.
21. Parasassi T, Martellucci A, Conti F, Messina B. Drug-membrane interactions: silymarin, silibyn and microsomal membranes. Cell Biochem Funct 1984; 2: 85-8.
22. Saija A, Scalese M, Lanza M, Marzullo D, Bonina F, Castelli F. Flavanoids as antioxidant agents: importance of their interaction with biomembranes. Free Radic Biol Med 1995; 19: 481-6.
23. Erlejman AG, Verstraeten SV, Fraga CG, Oteiza PI. The interaction of flavonoids with membranes: potential determinant of flavonoid antioxidant effects. Free Radic Res 2004; 38: 1311-20.
24. Oteiza PI, Erlejman AG, Verstraeten SV, Keen CL, Fraga CG. Flavonoid-membrane interactions: a protective role of flavonoids at the membrane surface? Clin Dev Immunol 2005; 12: 19-25.
25. Parasassi T, De Stasio G, d'Ubaldo A, Gratton E. Phase fluctuation in phospholipid membranes revealed by Laurdan fluorescence. Biophys J 1990; 57: 1179-86.
26. 3a A, Shirataki Y, Motohashi N, Michalak K. Differential interaction of Sophora isoflavonoids with lipid bilayers. Eur J Pharm Sci 2002; 16: 201-8.
27. Kocherginsky N, Swartz HM. Chemical reactivity of nitroxides in nitroxide spin labels. Boca Raton, FL: CRC Press; 1995.
28. Kaiser RD, London E. Location of diphenylhexatriene (DPH) and its derivatives within membranes: comparison of different fluorescence quenching analyses of membrane depth. Biochemistry 1998; 37: 8180-90.
29. Saija A, Bonina F, Trombetta D, Tomaino A, Montnegro L, Smeriglio P, et al. Flavonoid-biomembrane interactions: a calo rimetric study on dipalmitoylphosphatidylcholine vesicles. Int J Pharm 1995; 124: 1-8.
30. van Dijk C, Driessen AJ, Recourt K. The uncoupling efficiency and affinity of flavonoids for vesicles. Biochem Pharmacol 2000; 60: 1593-600.
31. Parasassi T, Krasnowska EK, Bagatolli L, Gratton E. Laurdan and Prodan as polarity-sensitive fluorescent membrane probes. J Fluorescence 1998; 8: 365-73.
32. Krasnowska EK, Gratton E, Parasassi T. Prodan as membrane surface fluorescence probe: partitioning between water and phospholipid phases. Biophys J 1998; 74: 1984-93.
33. Schoefer L, Braune A, Blaut M. A fluorescence quenching test for the detection of flavonoid transformation. FEMS Microbiol Lett 2001; 204: 277-80.
34. Stubbs CD, Ho C, Slater SJ. Fluorescence techniques for probing water penetration into lipid bilayers. J Fluorescence 1995; 5: 19-28.
35. Arora A, Byrem TM, Nair MG, Strasburg GM. Modulation of liposomal membrane fluidity by flavonoids and isoflavonoids. Arch Biochem Biophys 2000; 373: 102-9.
36. Scheidt HA, Pampel A, Nissler L, Gebhardt R, Huster D. Investigation of the membrane localization and distribution of flavonoids by high-resolution magic angle spinning NMR spectroscopy. Biochim Biophys Acta 2004; 1663: 97-107.
37. Jain MK, Wu NM. Effect of small molecules on the dipalmitoyl lecithin liposomal bilayer: III. Phase transition in lipid bilayer. J Membr Biol 1977; 34: 157-201.
38. Pawlikowska-Pawlega B, Gruszecki WI, Misiak LE, Gawron A. The study of the quercetin action on human erythrocyte membranes. Biochem Pharmacol 2003; 66: 605-12.